InterWest Partners and OrbiMed lead new round of financing focused on global corneal cross-linking opportunity. Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Today, more than 100,000 eyes around the…

RetroSense Therapeutics a biotechnology company raises $6M in a Series B financing. RetroSense Therapeutics is a biotechnology company that is developing a game-changing gene therapy to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) and advanced…